MyAverix Finance
SHG · Healthcare
Jiangsu GDK Biotechnology Co Ltd (688670)
Biotechnology
Jiangsu GDK Biotechnology Co Ltd (688670) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $2.17B, P/E ratio is 18.00, net margin is -153.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688670
Jiangsu GDK Biotechnology Co Ltd (688670) — FAQ
What is Jiangsu GDK Biotechnology Co Ltd's market cap?
Jiangsu GDK Biotechnology Co Ltd (688670) has a reported market cap of $2.17B (data as of 2026-03-29).
What is 688670's P/E ratio?
The price-to-earnings (P/E) ratio for Jiangsu GDK Biotechnology Co Ltd (688670) is 18.00 (data as of 2026-03-29).
Does Jiangsu GDK Biotechnology Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Jiangsu GDK Biotechnology Co Ltd (688670). Check the MyAverix Finance app for the latest dividend data.
What sector is Jiangsu GDK Biotechnology Co Ltd in?
Jiangsu GDK Biotechnology Co Ltd (688670) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688670 listed on?
688670 is listed on SHG.
What is Jiangsu GDK Biotechnology Co Ltd's net margin?
Jiangsu GDK Biotechnology Co Ltd (688670) reports a net margin of -153.2% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.